Benzinga | Nov 16, 2020 08:12AM EST

Retrophin Announces Corporate Name Change To Travere Therapeutics, Inc. And Ticker Change To 'TVTX' Effective Nov. 19

SAN DIEGO, Nov. 16, 2020 (GLOBE NEWSWIRE) -- Retrophin Inc., (NASDAQ:RTRX) today announced that the Company has changed its global corporate name to Travere Therapeutics, Inc. This new name reflects the Company's steadfast dedication to helping people as they navigate life with rare disease, as well as the forward momentum of its promising pipeline of potential first-in-class therapeutic candidates. In conjunction with the name change, the Company expects to begin trading under the new ticker symbol "TVTX" on the Nasdaq Global Select Market at market open on November 19, 2020.